PHIO PHARMACEUTICALS CORP. Dividends, Preferred Stock
PHIO PHARMACEUTICALS CORP. (PHIO) reported Dividends, Preferred Stock of $126.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Shareholders' Equity › Dividends, Preferred Stock
us-gaap:DividendsPreferredStock · last filed 2016-03-30
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for the quarter ending 2015-09-30 was -$1.00K, a 100.88% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for the quarter ending 2015-06-30 was $22.00K, a 86.67% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for the quarter ending 2015-03-31 was $105.00K, a 37.50% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for fiscal 2015 was $126.00K, a 78.86% decline from fiscal 2014.
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for fiscal 2014 was $596.00K, a 12.61% decline from fiscal 2013.
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for fiscal 2013 was $682.00K, a 79.43% decline from fiscal 2012.
- PHIO PHARMACEUTICALS CORP. dividends, preferred stock for fiscal 2012 was $3.31M.
| Period end | Dividends, Preferred Stock 3 month | Dividends, Preferred Stock 3 month as first filed | Dividends, Preferred Stock 6 month | Dividends, Preferred Stock 6 month as first filed | Dividends, Preferred Stock 9 month | Dividends, Preferred Stock 9 month as first filed | Dividends, Preferred Stock 12 month | Dividends, Preferred Stock 114 month | Dividends, Preferred Stock 117 month |
|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$1.00K derived: sum of 2 quarters · filed 2016-03-30 | $21.00K derived: sum of 3 quarters · filed 2016-03-30 | $126.00K 10-K · filed 2016-03-30 | |||||
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $21.00K derived: sum of 2 quarters · filed 2015-11-12 | $126.00K 10-Q · filed 2015-11-12 | $275.00K derived: sum of 4 quarters · filed 2016-03-30 | |||||
| 2015-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $127.00K 10-Q · filed 2015-08-12 | $276.00K derived: sum of 3 quarters · filed 2016-03-30 | $390.00K derived: sum of 4 quarters · filed 2016-03-30 | |||||
| 2015-03-31 | $105.00K 10-Q · filed 2015-05-13 | $254.00K derived: sum of 2 quarters · filed 2016-03-30 | $368.00K derived: sum of 3 quarters · filed 2016-03-30 | $533.00K derived: sum of 4 quarters · filed 2016-03-30 | |||||
| 2014-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $263.00K derived: sum of 2 quarters · filed 2016-03-30 | $428.00K derived: sum of 3 quarters · filed 2016-03-30 | $596.00K 10-K · filed 2016-03-30 | |||||
| 2014-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $279.00K derived: sum of 2 quarters · filed 2015-11-12 | $447.00K 10-Q · filed 2015-11-12 | $477.00K 10-Q · filed 2014-11-13 | $619.00K derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $333.00K 10-Q · filed 2015-08-12 | $505.00K derived: sum of 3 quarters · filed 2015-08-12 | -$4.93M derived: sum of 4 quarters · filed 2015-08-12 | |||||
| 2014-03-31 | $168.00K 10-Q · filed 2015-05-13 | $340.00K derived: sum of 2 quarters · filed 2015-05-13 | -$5.10M derived: sum of 3 quarters · filed 2015-05-13 | $680.00K derived: sum of 4 quarters · filed 2015-05-13 | |||||
| 2013-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$5.26M derived: sum of 2 quarters · filed 2015-03-30 | $512.00K derived: sum of 3 quarters · filed 2015-03-30 | $682.00K 10-K · filed 2015-03-30 | |||||
| 2013-09-30 | -$5.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $340.00K derived: sum of 2 quarters · filed 2014-11-13 | $510.00K 10-Q · filed 2014-11-13 | $1.71M derived: sum of 4 quarters · filed 2014-11-13 | |||||
| 2013-06-30 | $5.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $5.95M 10-Q · filed 2013-08-14 | $7.15M derived: sum of 3 quarters · filed 2014-05-14 | $8.14M derived: sum of 4 quarters · filed 2014-05-14 | |||||
| 2013-03-31 | $170.00K 10-Q · filed 2014-05-14 | $3.55M 10-Q · filed 2013-05-15 | $1.37M derived: sum of 2 quarters · filed 2014-05-14 | $2.37M derived: sum of 3 quarters · filed 2014-05-14 | |||||
| 2012-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $2.19M derived: sum of 2 quarters · filed 2013-03-29 | $3.31M 10-K · filed 2013-03-29 | ||||||
| 2012-09-30 | $994.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $2.11M 10-Q · filed 2012-11-13 | $2.11M 10-Q · filed 2012-11-13 | ||||||
| 2012-06-30 | $1.12M 10-Q · filed 2013-08-14 | $118.00K 10-Q · filed 2012-08-14 | $118.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |